Estimation of Control Before and After Treatment of a Depressive Episode With Serotonin Reuptake Inhibitors

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-55
SponsorHôpital le Vinatier

About this trial

The goal of this observational study is to better understand cognitive and affective processes involved in depression, in particular how individuals estimate their perception of control over events in their environment, as well as related processes such as memory and decision-making. The study also aims to investigate how these processes are affected by antidepressant treatment and how depressive symptoms evolve over time, as well as whether specific peripheral markers (including hormones) are associated with treatment effects.

Eligibility criteria

Qualifiers

Affiliated with a social security or national health insurance system, or entitled to such coverage.

Male or female, aged 18 to 55 years.

Fluent in spoken and written French.

Normal or corrected-to-normal vision.

Disqualifiers

History of a major depressive episode within the past 3 years.

Use of antidepressants, mood stabilizers, or antipsychotic medication within the past 3 years.

Diagnosis of a neurological or psychiatric disorder affecting central nervous system function (including bipolar disorder, schizophrenia, or other psychotic disorders according to DSM-5 criteria).

Pregnancy or breastfeeding (self-reported).

Trial design

Treatments tested in this trial

  • Selective Serotonin Reuptake Inhibitors (SSRIs) or serotonergic antidepressants
  • Experimental tasks

Treatment groups

124 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Hôpital le Vinatier

Lead sponsor

INSERM U1028

Collaborator